Skip to content

Study on the clinical effect of single injection of different doses of remazolam

Study on the clinical effect of single injection of different doses of remazolam

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088425
Enrollment
Unknown
Registered
2024-08-19
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedation before surgery

Interventions

Experimental group 1 ( R1 group ):The loading dose of remazolam was 0.2 mg/kg, and the injection time was 30 s.
Experimental group2 ( R2 group ):The loading dose of remazolam was 0.3 mg/kg, and the injection time was 30 s.
Experimental group3 ( R3 group ):The loading dose of remazolam was 0.4 mg/kg, and the injection time was 30 s.
Experimental group4 ( R4 group ):The loading dose of remazolam was 0.5 mg/kg, and the injection time was 30 s.
Experimental group5 ( R5 group ):The loading dose of remazolam was 0.6 mg/kg, and the injection time was 30 s.

Sponsors

Shaoxing Shangyu Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ( 1 ) American Society of Anesthesiologists ( ASA ) grade I-II ; ( 2 ) Aged 18 to 65 years, scheduled for elective non-cardiac surgery ; ( 3 ) Body mass index ( BMI ) was 18-28kg/m^2 ; ( 4 ) According to the provisions of the GCP, to obtain informed consent, volunteer to participate.

Exclusion criteria

Exclusion criteria: ( 1 ) Drug resistance to benzodiazepines or other anesthetics ; ( 2 ) Allergic or suspicious allergies to the drugs used in the study ; ( 3 ) Frequent use of antipsychotics or antidepressants, alcohol or drug dependence ; ( 4 ) BIS 2, with the possibility of respiratory tract management difficulties ; ( 6 ) History of obstructive sleep apnea syndrome ; ( 7 ) History of bronchiectasis and asthma ; ( 8 ) Arrhythmia ; ( 9 ) Neuromuscular diseases ; ( 10 ) Anesthesiologists considered it inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
BIS values;

Secondary

MeasureTime frame
SBP, Systolic Blood Pressure;DBP, diastolic blood pressure;HR, heart rate;SPO2;

Countries

China

Contacts

Public ContactChen Jianxiao

35 Banshan Road, Baiguan Street, Shangyu District, Shaoxing, Zhejiang, China

2756333089@qq.com+86 153 2523 8739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026